| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Recro Pharma Inc (NASDAQ: REPH)
REPH Technical Analysis
5
| As on 23rd May 2022 REPH STOCK Price closed @ 0.79 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.66 & Strong Sell for SHORT-TERM with Stoploss of 3.23 we also expect STOCK to react on Following IMPORTANT LEVELS. |
REPHSTOCK Price
| Open | 0.78 | Change | Price | % |
| High | 0.84 | 1 Day | 0.01 | 1.28 |
| Low | 0.78 | 1 Week | -0.21 | -21.00 |
| Close | 0.79 | 1 Month | -0.92 | -53.80 |
| Volume | 82972 | 1 Year | -1.52 | -65.80 |
| 52 Week High 5.04 | 52 Week Low 0.80 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| REPH Daily Charts |
REPH Intraday Charts |
Whats New @ Bazaartrend |
REPH Free Analysis |
|
|
REPH Important Levels Intraday
| RESISTANCE | 0.91 |
| RESISTANCE | 0.87 |
| RESISTANCE | 0.85 |
| RESISTANCE | 0.82 |
| SUPPORT | 0.76 |
| SUPPORT | 0.73 |
| SUPPORT | 0.71 |
| SUPPORT | 0.67 |
REPH Forecast April 2024
| 4th UP Forecast | 2.7 |
| 3rd UP Forecast | 2.09 |
| 2nd UP Forecast | 1.71 |
| 1st UP Forecast | 1.33 |
| 1st DOWN Forecast | 0.25 |
| 2nd DOWN Forecast | -0.13 |
| 3rd DOWN Forecast | -0.51 |
| 4th DOWN Forecast | -1.12 |
REPH Weekly Forecast
| 4th UP Forecast | 5.22 |
| 3rd UP Forecast | 3.80 |
| 2nd UP Forecast | 2.92 |
| 1st UP Forecast | 2.04 |
| 1st DOWN Forecast | -0.46 |
| 2nd DOWN Forecast | -1.34 |
| 3rd DOWN Forecast | -2.22 |
| 4th DOWN Forecast | -3.64 |
REPH Forecast2024
| 4th UP Forecast | 9.48 |
| 3rd UP Forecast | 6.69 |
| 2nd UP Forecast | 4.97 |
| 1st UP Forecast | 3.25 |
| 1st DOWN Forecast | -1.67 |
| 2nd DOWN Forecast | -3.39 |
| 3rd DOWN Forecast | -5.11 |
| 4th DOWN Forecast | -7.9 |
Recro Pharma Inc ( NASDAQ USA Symbol : REPH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
REPH Business Profile
Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania. Address: 1 E. Uwchlan Ave, Exton, PA, United States, 19341
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service